Anaphylaxis
Risk of severe allergic reaction. Seek urgent medical help if serious symptoms occur.
Leaflet ARZERRA 20mg / ml concentrate for solution for infusion
- Product code:
- W55663001
- Quantity:
- 3
- Indicated for:
- multiple sclerosis
- Route of administration:
- infusion
- Substance:
- ofatumumab (monoclonal antibody)
- ATC
- L01FA02 — Antineoplastic and immunomodulating agents | Monoclonal antibodies and antibody drug conjugates | Cd20 (clusters of differentiation 20) inhibitors
Precautions:
Additional monitoring
This medicine is subject to additional monitoring.
Breastfeeding warning
Use during breastfeeding only on medical advice.
Pregnancy warning
Use during pregnancy only on medical advice.
Ofatumumab is a monoclonal antibody used for the treatment of relapsing multiple sclerosis and chronic lymphocytic leukemia. It works by targeting the CD20 protein on the surface of B lymphocytes, thereby destroying these cells and reducing disease activity.
The medication is administered via subcutaneous injection or intravenous infusion, as directed by a doctor. The dosage and frequency of administration are adjusted based on the condition being treated and the patient's response.
Patients should be monitored for potential side effects, such as injection site reactions, infections, or fever. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions, upper respiratory tract infections, fever, and headaches. In rare cases, severe reactions such as serious infections or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
The medication is administered via subcutaneous injection or intravenous infusion, as directed by a doctor. The dosage and frequency of administration are adjusted based on the condition being treated and the patient's response.
Patients should be monitored for potential side effects, such as injection site reactions, infections, or fever. It is important to inform the doctor of any unusual symptoms.
Common side effects include injection site reactions, upper respiratory tract infections, fever, and headaches. In rare cases, severe reactions such as serious infections or allergic reactions may occur. Patients should be informed of these risks before starting treatment.
General data about ARZERRA 20mg / ml
- Substance:
- ofatumumab
- Date of latest medicines list:
- 01-01-2014
- Product code:
- W55663001
- Concentration:
- 20mg / ml
- Pharmaceutical form:
- concentrate for solution for infusion
- Quantity:
- 3
- Product type:
- Original
- Prescription status:
- S — Medicines dispensed with a restricted medical prescription, reserved for use in certain specialized fields.